421 related articles for article (PubMed ID: 30992569)
1. Towards individualized therapy for metastatic renal cell carcinoma.
Kotecha RR; Motzer RJ; Voss MH
Nat Rev Clin Oncol; 2019 Oct; 16(10):621-633. PubMed ID: 30992569
[TBL] [Abstract][Full Text] [Related]
2. Genomic classifications of renal cell carcinoma: a critical step towards the future application of personalized kidney cancer care with pan-omics precision.
Hsieh JJ; Le V; Cao D; Cheng EH; Creighton CJ
J Pathol; 2018 Apr; 244(5):525-537. PubMed ID: 29266437
[TBL] [Abstract][Full Text] [Related]
3. Metastatic renal cell carcinoma: many treatment options, one patient.
Rini BI
J Clin Oncol; 2009 Jul; 27(19):3225-34. PubMed ID: 19470934
[TBL] [Abstract][Full Text] [Related]
4. [Novel biomarkers in renal cell carcinoma. Identification and functional characterization].
Macher-Göppinger S
Pathologe; 2015 Nov; 36 Suppl 2():201-4. PubMed ID: 26362327
[TBL] [Abstract][Full Text] [Related]
5. The genomics of renal cell carcinoma and its role in renal mass biopsy.
Salami SS; George AK; Udager AM
Curr Opin Urol; 2018 Jul; 28(4):383-391. PubMed ID: 29708949
[TBL] [Abstract][Full Text] [Related]
6. Complexity of the genomic landscape of renal cell carcinoma: Implications for targeted therapy and precision immuno-oncology.
Sanfrancesco JM; Cheng L
Crit Rev Oncol Hematol; 2017 Nov; 119():23-28. PubMed ID: 29065981
[TBL] [Abstract][Full Text] [Related]
7. On-treatment biomarkers in metastatic renal cell carcinoma: towards individualization of prognosis?
Donskov F; Heng DY; Rini BI
Expert Rev Anticancer Ther; 2017 Feb; 17(2):97-99. PubMed ID: 27927054
[No Abstract] [Full Text] [Related]
8. Genetic pathways involved in carcinogenesis of clear cell renal cell carcinoma: genomics towards personalized medicine.
Audenet F; Yates DR; Cancel-Tassin G; Cussenot O; Rouprêt M
BJU Int; 2012 Jun; 109(12):1864-70. PubMed ID: 22035299
[TBL] [Abstract][Full Text] [Related]
9. [Personalised medicine in renal cell tumours].
Junker K; Zeuschner P
Aktuelle Urol; 2019 Sep; 50(5):513-523. PubMed ID: 31167243
[TBL] [Abstract][Full Text] [Related]
10. Targeted therapies for renal cell carcinoma.
Posadas EM; Limvorasak S; Figlin RA
Nat Rev Nephrol; 2017 Aug; 13(8):496-511. PubMed ID: 28691713
[TBL] [Abstract][Full Text] [Related]
11. Personalized Management of Advanced Kidney Cancer.
Graham J; Heng DYC; Brugarolas J; Vaishampayan U
Am Soc Clin Oncol Educ Book; 2018 May; 38():330-341. PubMed ID: 30231375
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in the treatment of advanced renal cell carcinoma: towards multidisciplinary personalized care.
Bex A; Gore M; Mulders P; Sternberg CN
BJU Int; 2012 Nov; 110(9):1289-300. PubMed ID: 22624610
[TBL] [Abstract][Full Text] [Related]
13. A new patient-focused approach to the treatment of metastatic renal cell carcinoma: establishing customized treatment options.
Bellmunt J; Eisen T; Szczylik C; Mulders P; Porta C
BJU Int; 2011 Apr; 107(8):1190-9. PubMed ID: 21078050
[TBL] [Abstract][Full Text] [Related]
14. Tumor Microenvironment Dynamics in Clear-Cell Renal Cell Carcinoma.
Vuong L; Kotecha RR; Voss MH; Hakimi AA
Cancer Discov; 2019 Oct; 9(10):1349-1357. PubMed ID: 31527133
[TBL] [Abstract][Full Text] [Related]
15. Genomics of renal cell cancer: the biology behind and the therapy ahead.
Jones J; Libermann TA
Clin Cancer Res; 2007 Jan; 13(2 Pt 2):685s-692s. PubMed ID: 17255294
[TBL] [Abstract][Full Text] [Related]
16. Changes in Treatment Reality and Survival of Patients With Advanced Clear Cell Renal Cell Carcinoma - Analyses From the German Clinical RCC-Registry.
Goebell PJ; Staehler M; Müller L; Nusch A; Scheffler M; Sauer A; von Verschuer U; Tech S; Kruggel L; Jänicke M; Marschner N;
Clin Genitourin Cancer; 2018 Dec; 16(6):e1101-e1115. PubMed ID: 30061035
[TBL] [Abstract][Full Text] [Related]
17. The use of cytoreductive nephrectomy in patients with renal cell carcinoma.
Ghandour RA; Singla N; Margulis V
Expert Rev Anticancer Ther; 2019 May; 19(5):405-411. PubMed ID: 31020871
[TBL] [Abstract][Full Text] [Related]
18. Molecular-based therapies for renal cell carcinoma.
Zisman A; Pantuck AJ; Belldegrun AS
Curr Urol Rep; 2001 Feb; 2(1):55-61. PubMed ID: 12084296
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant therapy for advanced renal cell carcinoma.
Meissner MA; McCormick BZ; Karam JA; Wood CG
Expert Rev Anticancer Ther; 2018 Jul; 18(7):663-671. PubMed ID: 29707987
[TBL] [Abstract][Full Text] [Related]
20. Current status of prognostic factors in patients with metastatic renal cell carcinoma.
Teishima J; Inoue S; Hayashi T; Matsubara A
Int J Urol; 2019 Jun; 26(6):608-617. PubMed ID: 30959579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]